Wound healing remains a substantial clinical challenge, especially for individuals suffering from chronic medical conditions such as diabetes where impaired tissue repair drives considerable morbidity and mortality. Conventional static wound dressings and standard three-dimensional bioprinted constructs fail to adapt dynamically to the rapidly evolving biochemical and biophysical microenvironment found within an active healing wound. To address these operational shortcomings, four-dimensional bioprinting incorporates time as a programmable fabrication dimension, introducing printed tissue scaffolds capable of undergoing controlled physical shape morphing, triggered therapeutic drug release, and functional adaptation when exposed to microenvironmental cues such as temperature changes, fluctuating pH levels, reactive oxygen species, light, magnetic fields, and local enzymatic activity.
A critical narrative review adopts an operational definition of four-dimensional bioprinting and applies it as an inclusion criterion to evaluate current research. Under this inclusion framework, genuine four-dimensional bioprinting requires additive fabrication that positions living cells or cell-instructive matrix under precise spatial control, embeds an intended transformation directly into that spatial layout during printing, and yields a measurable post-fabrication physical or functional change governed by a clearly defined trigger, threshold, and actuation rate.
When evaluated strictly against these three additive fabrication benchmarks, a significant portion of current published work presented as four-dimensional bioprinting actually comprises cast responsive hydrogels, electrospun fibrous meshes, microneedle arrays, and conventional smart dressings.
The review closely examines the foundational design levers that govern the physical magnitude, geometric direction, and kinetic rate of post-printing shape morphing in dynamic matrices. Alongside external stimulus triggers, the authors highlight cell-generated contractile force operating as an endogenous mechanical actuator capable of driving scaffold architectural changes from within the cellularized structure itself.
Designing effective responsive scaffolds also demands careful attention to specific physiological measurement caveats that qualify wound pH, localized tissue temperature, and elevated reactive oxygen species as clinical targets.
The evaluation identifies critical failure modes peculiar to four-dimensional bioprinting platforms that currently impede reliable wound care deployment.
Substantial translation gaps persist across the entire biofabrication sector, as experimental evidence remains overwhelmingly confined to rodent-based animal models.
Crucially, the investigators emphasize that virtually no published research compares an adaptive, stimuli-responsive dynamic construct directly against a compositionally identical static control scaffold.
Subject of Research: Evaluation of 4D bioprinted dynamic skin constructs and stimuli-responsive materials for adaptive wound healing
Article Title: 4D bioprinting of dynamic skin constructs: stimuli-responsive materials for adaptive wound healing
Article References: Chandrasekaran, S., Duraisamy, N., Jagadeesan, M., Pachaiappan, R., Digala, P., & Anbu, P. (2026). 4D bioprinting of dynamic skin constructs: stimuli-responsive materials for adaptive wound healing. 3 Biotech, 16(12), Article 506. https://doi.org/10.1007/s13205-026-05118-x
Image Credits: AI Generated
DOI: 10.1007/s13205-026-05118-x
Keywords: 4D bioprinting, wound healing, stimuli-responsive materials, skin constructs, biofabrication, shape morphing, chronic wounds, diabetes, hydrogels, biomaterials, tissue engineering, ASTM biofabrication families, reactive oxygen species, wound microenvironment, cell-generated contractile force, smart dressings, preclinical research
News Source: Gregory Coleman. (November 13, 2026). Dynamic 4D Bioprinted Skin Constructs Face Practical Roadblocks in Early Wound Research. Scienmag.



